QIAGEN Receives FDA Approval to Expand Use of EGFR Test in Lung Cancer

Product News   Jan 21, 2018

 
QIAGEN Receives FDA Approval to Expand Use of EGFR Test in Lung Cancer
 
 
FURTHER INFORMATION
 
 
 

Related Product News

QIAGEN Announces European Launch of QIAstat-Dx

Product News

Posters by early adopters demonstrate accurate, fast, cost-effective and flexible diagnosis of syndromic infections and other diseases in unique and versatile Sample to Insight workflows.

READ MORE

Cobra Biologics Receives the Queen’s Award for Enterprise in International Trade

Product News

The UK’s most prestigious business award granted in recognition of outstanding achievement in the export of services for gene and immunotherapy products.

READ MORE

Flow Chemistry Improves Control of Nanoprecipitation

Product News

Syrris, a world leader in chemistry product innovation, continues to support pioneering research into nanoparticle drug encapsulation, thanks to its award-winning Asia range of advanced flow chemistry modules.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE